Skip to content

Debatforum

20.6k Emner 126.8k Indlæg

Aktie- og finansdebat

  • Chemm

    2
    0 Votes
    2 Indlæg
    0 Visninger
    V
    Statusopgørelse: Ser man på de 3 seneste regnskabsår fremgår det at 1. kvartal udgjorde henholdsvis: 2016/2017: 20% 2017/2018: 21.3% 2018/2019: 19.3% Historisk er 1. kvartal det svageste kvartal og udgør kun 1/5 af årsomsætningen. Ser vi fremad i indeværende regnskabsår giver dette en indikation om et helårsregnskab på 48.8 x 5 = 244 mio. På nuværende tidspunkt forventer Chemometec en omsætning på 200 - 209 mio, altså hele 35 mio under ovenstående udregning. Der er således stor sandsynlighed for mindst 2 opjusteringer yderliger i dette regnskabsår. Med en støt stigende EBITDA-marginen, som nu er kravlet op på hele 43% kan dette regnskabsår kun blive kanon år. EBITDA kunne se således ud: 244 mio x 43% = 105 mio Og et driftoverskud på: 105 mio x 65% = 68 mio - eller en EPS på 68/16,3 = 4.2. Dette sammenholdt med uddrag fra årsberetningen: Kunderne vurderer NC-200 som både brugervenlig og testresultaterne som meget konsistente. Disse egenskaber ser ikke ud til at kunne leveres af nogen af de konkurrerende produkter på celletællingsmarkedet. Konklusion: Bluesky scenarie, en aktie der skal holdes.
  • SAS - opjustering og fest!

    2
    0 Votes
    2 Indlæg
    0 Visninger
    A
    SAS er i formiddag kommet med en opjustering af årsresultatet til 700-800 mio ynkelige svenske kroner før skat. Det skal sammenholdes med at SAS efter 3 kvartalsregnskabet for ca. 3 mdr. siden meldte, at det ville være udfordrene at nå et positivt resultat for året. Vi kan nu konstatere, at der er mange penge i luftfart, når det svinger rigtigt. Og det ser det ud til at gøre for SAS for tiden. Så mon ikke man roligt kan sætte tilbagelænet og nyde flyveturen?
  • Iss

    2
    0 Votes
    2 Indlæg
    0 Visninger
    J
    Carnegie Løfter fra sælg til hold. Skal nok lidt op i dag - men den var også kommet for langt ned
  • VESTAS Q3 REGNSKAB

    7
    0 Votes
    7 Indlæg
    0 Visninger
    Helge_LarsenPI-redaktørH
    "Den danske vindmøllegigant Vestas lander en driftsmargin (ebit) før særlige poster på 11,8 pct. i årets tredje kvartal. Dermed slår selskabet analytikerforventningen, der forud for regnskabet lå på 10,7 pct. Det fremgår af regnskabet for tredje kvartal, der netop er blevet offentliggjort. På toplinjen omsatte Vestas i årets tredje kvartal for 3646 mio. euro mod en analytikerforventning på 3301 mio. euro forud for regnskabet og et resultat i samme periode sidste år på 2811 mio. euro. Det svarer til en omsætningsvækst på 30 pct. På bundlinjen kommer vindmøllegiganten ud af tredje kvartal med et plus på 303 mio. euro. Der er også højere end de 259 mio. euro, som var forventet blandt analytikerkorpset. I samme periode sidste år realiserede Vestas et overskud på 178 mio. euro". https://borsen.dk/nyheder/virksomheder/artikel/1/390805/vestas_trumfer_forventningerne_til_indtjening_-_oeger_omsaetning_med_30_pct.html?utm_source=forside&utm_campaign=nyhed_01
  • Ørsted hvem skal man tro på.rbc cipital eller oddo.???

    0
    0 Votes
    0 Indlæg
    0 Visninger
    C
    Der er kommet to udmeldning . Den ene er fra rbc Capital markets de siger nu 640 fra 600 og oddo siger sælg til 500. Hvem skal man tro på...
  • Zealand Pharma - Erfaringer fra årets børsraket

    21
    0 Votes
    21 Indlæg
    0 Visninger
    Helge_LarsenPI-redaktørH
    "Zealand Pharma kandiderer til titlen som årets børsraket efter en stigning, som har mere end fordoblet aktieværdien hidtil i 2019. Udover selve stigningen, som kan være nok så behagelig, rummer udviklingen også andre ting som investorerne med fordel kan "tage med sig" og som andre selskaber også burde lade sig inspirere af": Video med Investeringsøkonom Per Hansen: https://blog.nordnet.dk/zealand-pharma-aarets-boersraket/?autoplay=1
  • Veloxis

    4
    0 Votes
    4 Indlæg
    0 Visninger
    B
    Hej jeg er ny her på Proinvestor, hvor finder man en tråd om Veloxis som går helt grasat op ad i disse dage. Er der nogen som har et langsigtet target på den.
  • vestas

    4
    0 Votes
    4 Indlæg
    0 Visninger
    B
    Hvad tid kommer der regnskab i dag
  • Transcript of GEN.CO earnings conference call Q3

    0
    0 Votes
    0 Indlæg
    0 Visninger
    Helge_LarsenPI-redaktørH
    Q3 2019 Genmab A/S Earnings Call Copenhagen Nov 7, 2019 (Thomson StreetEvents) -- Edited Transcript of Genmab A/S earnings conference call or presentation Wednesday, November 6, 2019 at 5:00:00pm GMT TEXT version of Transcript: https://finance.yahoo.com/news/edited-transcript-gen-co-earnings-025347509.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAJtZp3E8Cet0l7vZK7LAS6GucE1cfLJu8gXCPglnjggm58ByFJJ42nbfjopOB0iZFjOa-Sid2oZdVWgDEgLzgk1Lam9Hch4X7YUbQg_6aJ9eZPcMLogKu5ghCoVi9z3QqWX-vEFUFEBtVp-c6aVQ2hYYhutbERLd9JDy-TEu2Cp_
  • GRIEG SEAFOOD - Q3

    0
    0 Votes
    0 Indlæg
    0 Visninger
    Helge_LarsenPI-redaktørH
    Driftsresultat (ebit) før værdijustering av biomassen på 153,9 millioner kroner i årets tredje kvartal, ned fra 159,7 millioner året før. Driftsresultatet før af- og nedskrivninger (ebitda) landet i samme periode på 259,5 millioner kroner, op fra 218,9 millioner kroner året før. Totale salgsindtægter på 2,01 milliarder kroner, op fra 1,58 milliarder kroner i samme kvartal i fjor". https://newsweb.oslobors.no/message/488777 [image: 78883_Grieg_Group.jpg]
  • ZIP - En genial news-søgemaskine for investorer

    2
    0 Votes
    2 Indlæg
    0 Visninger
    Helge_LarsenPI-redaktørH
    Prøv lige at teste denne søgemaskine af på dine favoritaktier. Du er også velkommen til at skrive "Proinvestor" i søgefeltet. https://zip.news/dk/index.html?ordering=PUBLISH_DATE&country=DK&query=genmab
  • NorthMedia Q3

    7
    0 Votes
    7 Indlæg
    0 Visninger
    MatchM
    På torsdag kommer der Q3 resultat fra NorthMedia. Den mest undervurderede aktie på fondsbørsen. Forventet omsætning 1.110-1.160 mio. kr. EBIT før særlige poster 120-140 mio. kr. P/e på omkring 6,0 - omkring 80 mio. kr. i overskud af aktieinvesteringer. Og så roder den konstant rundt i et kursniveau på mellem 36 og 37 kr.
  • NorthMedia

    3
    0 Votes
    3 Indlæg
    0 Visninger
    MatchM
    Så kom opjusteringen. FK Distribution klarer sig bedre end forventet, også ind i Q4. Dejligt!
  • Donation

    1
    0 Votes
    1 Indlæg
    0 Visninger
    L
    Er sendt af sted. Fortsæt det FANTASTISKE arbejde. TAK
  • Er løbet kørt for disse 4 aktier?

    3
    0 Votes
    3 Indlæg
    0 Visninger
    M
    Her er 4 aktier, som mange har spurgt på. Spørgsmålene går primært på, om det er for sent at komme med. Helt generelt er jeg jo trendfollower, så jeg er jo glad for aktier, der allerede er steget. Men lad os kigge på dem. Aktierne er: Bakkafrost Veloxis Chemometec Zealand Pharma https://www.youtube.com/watch?v=qynusLTXDfE
  • Pandora stiger

    40
    0 Votes
    40 Indlæg
    0 Visninger
    E
    Nu har jeg fulgt aktien de sidste 2-3 uger hvor den er steget stødt og nærmer sig de 300. Hvad er jeres bud på de kommende dage og uger. Regnskab kommer 4.11.2019. Jeg tror selv fortsat på stødt stigning til d. 4.11 og hvis det viser sig at de holder guidance og måske en overraskelse så eksploderer den vel?
  • Euroinvestor.dk - børsnoteret?

    19
    0 Votes
    19 Indlæg
    0 Visninger
    U
    Kan ikke huske om Euroinvestor stadig er børsnoteret, men her er de aktuelle tal fra Dansk Online Index ihvertfald. 34 euroinvestor.dk (Berlingske Media) 106.931 (-76%) 1.525.167 (-52%) 4.234.900 (-55%) 22.685 (-59%) 00:06:15 (-2%)
  • Feer n greed

    9
    0 Votes
    9 Indlæg
    0 Visninger
    U
    https://money.cnn.com/data/fear-and-greed/ - ret højt for tiden....FeAr n greed
  • Jyske Bank - nogle tanker en perfekt value aktie

    7
    0 Votes
    7 Indlæg
    0 Visninger
    E
    Jeg har reelt først købt mig ind i denne for relativ kort tid siden og har pt et mindre tab. Ifm min investering har jeg været inde og studere aktien og kan se følgende fakta: Indre værdi pr aktie efter 3 kvt 2019 kr. 418 - indre værdi pr aktie efter 3 kvt 2018 kr. 382. Pt. tilbage købt egne aktier for kr. 370 mio - opdateret tilbagekøb med ydeligere kr. 500 mio, dvs der skal tilbagekøbs ydeligere for 630 mio eller ca. 3-4% af kapitalen - det betyder en forøgelse pr aktie på ca. 7-8 kr udfra nuværende kursniveau i perioden 1/10 - 31/3 20202 eller ca. kr. 3,5-4 pr aktie i kvartalet, indregner vi en indtjening pr aktie pr kvt på gennemsnittet i år (kr 17 : 3) får vi en indtjening pr aktie på 5,7 - det giver for mig at se et samlet resultat at indre værdi pr aktie vil blive forøget med kr. 11,2 - 11,7 de næste to kvartaler ved uændret kursniveau - dette svare til en forretning omregnet til årsbasis på ca. 20%.. dvs. en indre værdi pr aktie på kr. 440 pr. 31/3 2020..
  • BAKKAFROST - Q3 2019

    3
    0 Votes
    3 Indlæg
    0 Visninger
    Helge_LarsenPI-redaktørH
    BAKKAFROST: Operational EBIT of DKK 303 Million for the Third Quarter of 2019 The Bakkafrost Group delivered a total operational EBIT of DKK 303.4 million in Q3 2019. Harvested volumes were 12.9 thousand tonnes gutted weight. The combined farming and VAP segments made an operational EBIT of DKK 257.3 million. The farming segment made an operational EBIT of DKK 231.5 million. The salmon spot prices decreased significantly in Q3 2019, compared to the previous quarter. The price decrease had a negative effect on the operational EBIT in the farming segment, while it had a positive effect on the operational EBIT in the VAP segment. The VAP segment made an operational EBIT of DKK 25.9 million. The EBITDA for the FOF segment was DKK 94.5 million. (Figures in parenthesis refer to the same period last year unless otherwise specified) The Group made a profit for Q3 2019 of DKK 180.9 million (DKK 355.9 million). For the first nine months of 2019, the profit was DKK 582.4 million (DKK 966.9 million). Commenting on the result, CEO Regin Jacobsen said: "Despite 10% lower salmon spot prices during the third quarter for 2019, compared to the same quarter last year, Bakkafrost has delivered strong operational results this quarter. The average size of the harvested salmon has been exceptionally high, which has put us in a very good position to withstand the difficult market situation. The biological performance has been very good with high growth rates for the salmon. Sea lice and mortality rates have been amongst the lowest for many years. This is a result of committed and skilled employees and a strong effort on a continuous improvement of the biology and the welfare of the salmon." The total volumes harvested in Q3 2019 were 12,938 tonnes gutted weight (7,217 tgw). Total harvested volumes in the first nine months of 2019 were 39,254 tonnes gutted weight (32,356 tgw). The guidance for harvest in 2019 is maintained at 54,500 tonnes gutted weight. 2.4 million (3.3 million) smolts were transferred during Q3 2019. During the first nine months of 2019, 7.7 million (9.2 million) smolts were transferred. 0.8 million smolts - out of the 13.5 million smolts, which were expected to be released in 2019 - will be postponed for release in Q1 2020 in order to reduce the risk associated with smolt release during the coldest weeks of the year. Thus, the new expected smolt release for 2019 is 12.7 million smolts. he combined farming and VAP segments made an operational EBIT of DKK 257.3 million (DKK 142.4 million) in Q3 2019. The operational EBIT per kg in Q3 2018 was DKK 19.89 (DKK 19.73), which corresponds to NOK 26.25 (NOK 25.34) for the combined farming and VAP segments. For the first nine months of 2019, the combined farming and VAP segments made an operational EBIT of DKK 791.8 million (DKK 735.5 million). The farming segment made an operational EBIT of DKK 231.5 million (DKK 139.6 million) in Q3 2019. The harvested volumes were higher, but the achieved prices were lower in Q3 2019, compared to Q3 2018. For the first nine months of 2019, the operational EBIT was DKK 764.7 million (DKK 761.3 million). The VAP segment made an operational EBIT of DKK 25.9 million (DKK 2.8 million) for Q3 2019. For the first nine months of 2019, the operational EBIT was DKK 27.1 million (DKK -25.8 million). The FOF segment (fishmeal, oil and feed) made an EBITDA of DKK 94.5 million (DKK 41.4 million) for Q3 2019, and the EBITDA margin was 19.5% (11.7%). The EBITDA was DKK 218.1 million for the first nine months of 2019 (DKK 193.9 million), corresponding to an EBITDA margin of 20.8% (19.8%). During Q3 2019, Havsbrún sourced 17,845 tonnes (7,496 tonnes) of raw material, and for the first nine months of 2019, Havsbrún sourced 243,484 tonnes (255,987 tonnes) of raw material. On 25 September 2019, Bakkafrost signed a Share Purchase Agreement to acquire 68.6% of the outstanding shares in the Scottish Salmon Company (SSC) from Northern Link Ltd. The closing date is 8 October 2019. Following the signing of the Share Purchase Agreement Bakkafrost acquired additional 9.2% of the shares in SSC in Q3 2019. SSC is a fully integrated salmon farming business operating exclusively in Scotland with 60 sites across the West Coast and Hebridean Islands. The company is engaged in nearly all stages of the value chain ensuring full traceability and total supply chain integrity. The current annual production capacity is 50,000 tonnes. SSC produced 29,913 tonnes gutted weight in 2018 and exported to 26 countries with a focus on North America and the Far East. SSC has developed a range of strong flagship brands, including Native Hebridean Salmon, Tartan Salmon Label Rouge and Lochlander Salmon. The company has over 600 employees. Bakkafrost has chosen to increase the company's share capital for the acquisition of SSC. The acquisition is therefore carried out without substantial increase in Bakkafrost's external financing. The net interest-bearing debt amounted to DKK -1,271.5 million, and thus positive, at the end of Q3 2019 (DKK 495.5 million at year-end 2018). Undrawn credit facilities amounted to DKK 1,481.0 million at the end of Q3 2019. The equity ratio was 68% at 30 September 2019, compared to 70% at the end of 2018. OUTLOOK Market According to the latest estimate from Kontali Analyse the global supply of Atlantic salmon in Q3 2019 increased around 13%, compared to Q3 2018. The global harvest of Atlantic salmon in Q4 2019 is expected to increase 3%, compared to Q4 2018. The estimated global supply of Atlantic salmon for 2019 is an increase of around 7%, compared to 2018. The supply of Atlantic salmon will be tight in 2020, as global supply in 2020 is estimated to increase around 4%, compared to estimated supply in 2019. Bakkafrost operates in the main salmon markets, Europe, USA, the Far East and Russia. Variation in sales distribution between the different markets is driven by the change in demand from quarter to quarter in the different regions. Bakkafrost, however, aims to have a balanced market diversification to reduce market risk. Farming The outlook for the farming segment is good. The estimates for harvest volumes and smolt releases are dependent on the biological development. Bakkafrost focuses on reducing biological risk continuously and has made several new investments and procedures to diminish this risk. Bakkafrost focuses on using non-medical methods in treatments against sea lice and has invested in new technology to follow this strategy. The biological performance in 2019 has been strong with good growth and low mortality rates. There are clear signs that the large smolt and non-medical delousing strategies are working successfully. Bakkafrost's guidance for harvest in 2019 is maintained at 54,500 tonnes gutted weight. In 2020, Bakkafrost expects to harvest 57,000 tonnes gutted weight, excluding the harvest from The Scottish Salmon Company. Bakkafrost expects to release 12.7 million smolts in 2019, compared to 12.6 million smolts in 2018 and 9.9 million smolts in 2017. This is 0.8 million smolts less than previously expected and is caused by the decision to postpone the release of 0.8 million smolts to Q1 2020 hereby reducing the risk associated with releasing smolt during the coldest weeks of the year. This is made possible by the increased smolt capacity on land from the Strond hatchery. Bakkafrost expects to release 15.0 million smolts in 2020, excluding the smolt release in The Scottish Salmon Company. The number of smolts released is a key element of predicting Bakkafrost's future production. VAP (Value Added Products) Bakkafrost has signed contracts covering around 40% for the expected harvested volumes in Q4 2019 and 26% for the harvest volume of 2020. Bakkafrost's long -term strategy is to sell around 40-50% of the harvested volumes of salmon as VAP products at fixed price contracts. The VAP contracts are at fixed prices, based on the salmon forward prices at the time they are agreed and the expectations for the salmon spot price for the contract period. The contracts last for 6 to 12 months. FOF (Fishmeal, Oil and Feed) The outlook for the production of fishmeal and fish oil is dependent on the availability of raw material. The ICES 2019 recommendation for blue whiting is 1,143 thousand tonnes, which corresponds to a decrease of 18%, compared to ICES's recommendation for 2018. The ICES 2020 recommendation for blue whiting is 1,162 thousand tonnes. Bakkafrost expects a decrease in production volumes of fishmeal and fish oil in 2019, compared to 2018. Havsbrún has increased the expectation for sales of fish feed in 2019 to be at 98,000 tonnes, depending on external sales. Havsbrún's sales of fish feed for 2020 is expected to be 110,000 tonnes. The major market for Havsbrún´s fish feed is the local Faroese market including Bakkafrost's internal use of fish feed. Investments Bakkafrost's investment program for the period from 2019 to 2022, excluding investments in The Scottish Salmon Company, will amount to DKK 2.5 billion, including maintenance capex, and will reinforce Bakkafrost's integrated business model and ensure a capacity across the value chain to be able to produce 100,000 tonnes gutted weight of salmon. The aim of the investment program is to minimize the biological risk, increase efficiency and create sustainable organic growth. Bakkafrost's focus on producing larger smolts plays a key role in achieving this goal. Financial Favourable market balances in the world market for salmon products and cost -conscious production will likely maintain the financial flexibility going forward. A high equity ratio together with Bakkafrost's bank financing, makes Bakkafrost's financial situation strong. This enables Bakkafrost to carry out its investment plans to further focus on strengthening the Group, M&A's, organic growth opportunities and to fulfil its dividend policy in the future, which is unchanged although a new investment program is announced. During Q3 2019, Bakkafrost increased the company's share capital for the acquisition of SSC. The acquisition was therefore carried out without substantial increase in Bakkafrost's external financing. Acquisitions In Q3 2019, Bakkafrost signed a binding Share Purchase Agreement to acquire 68.6% of The Scottish Salmon Company (SSC) to be closed in Q4 2019. This was followed by an acquisition of additional 9.2% of the shares in SSC in Q3 2019. Bakkafrost intends to acquire the remaining shares of SSC during Q4 2019. Bakkafrost will do this through a mandatory offer for the remaining shares in SSC, followed by a compulsory offer for the last 10% of the shares in case more than 90% ownership is reached by the mandatory offer. At the time of publication of this report (5 Nov 2019), Bakkafrost has acquired additional shares in SSC and holds a total of 80.77% of the shares. The acquisition of SSC is financed by issuing new shares in Bakkafrost, and Bakkafrost intends to delist SSC from Oslo Børs if 100% ownership of the company is obtained. More information about the acquisition of SSC, including the strategic rationale behind the acquisition, can be found in Note 9 in the Company's Q3 2019 report. Please find the Company's Q3 2019 report and the Q3 2019 presentation enclosed. Contacts: · Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) · Høgni Dahl Jakobsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. About Bakkafrost Bakkafrost is the largest salmon farmer in the Faroe Islands. The Group is fully integrated from feed production to smolt, farming, VAP and sales. The Group has production of fishmeal, fish oil and salmon feed in Fuglafjørður. The Group has primary processing in Glyvrar and Vágur, and secondary processing (VAP) in Glyvrar. The Group operates sea farming in Norðoyggjar, Eysturoy, Streymoy and Suðuroy. The Group has broodstock operations in Streymoy and Sandoy and is building a biogas plant in Streymoy. The headquarter is located in Glyvrar, and the company has 1.055 employees. In Q3 2019 the Group signed a Share Purchase Agreement to acquire 68,6% of the shares in The Scottish Salmon Company. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities. The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada or Japan. www.oslobors.no https://newsweb.oslobors.no/message/488561 [image: 78724_Laks.jpg]